Citation Impact
Citing Papers
Global Cancer in Women: Burden and Trends
2017
Combination of Photodynamic Therapy and Specific Immunotherapy Efficiently Eradicates Established Tumors
2015
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Cancer statistics, 2022
2022 Standout
Cancer statistics, 2023
2023 Standout
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
2019 Standout
A systematic review and meta-analysis on the prevalence of Escherichia coli and extended-spectrum β-lactamase-producing Escherichia coli in pregnant women
2021
Point-of-care bulk testing for SARS-CoV-2 by combining hybridization capture with improved colorimetric LAMP
2021 StandoutNobel
Cancer statistics, 2020
2020 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Cancer Statistics, 2021
2021 Standout
Trends in cervical cancer incidence rates by age, race/ethnicity, histological subtype, and stage at diagnosis in the United States
2019
Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women
2010
The Pap Test and Bethesda 2014
2015
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
2010 Standout
Expanding global access to radiotherapy
2015 Standout
A view on drug resistance in cancer
2019 StandoutNature
The epidemiology of human papillomavirus infections
2005
Global health burden and needs of transgender populations: a review
2016 Standout
50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence
2014
The biology and management of non-small cell lung cancer
2018 StandoutNature
Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
2011
Recent advances in strategies for immunotherapy of human papillomavirus‐induced lesions
2007
Clinical trials of human papillomavirus vaccines and beyond
2013
The biological properties of E6 and E7 oncoproteins from human papillomaviruses
2009
Changes in Pathogens Causing Early-Onset Sepsis in Very-Low-Birth-Weight Infants
2002
Structure of Dengue Virus
2002 Standout
Human papillomavirus types in 115,789 HPV‐positive women: A meta‐analysis from cervical infection to cancer
2012
Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials
2015
Evaluation of self-collected vaginal specimens for the detection of high-risk human papillomavirus infection and the prediction of high-grade cervical intraepithelial lesions in a high-burden, low-resource setting
2018
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
2015 Standout
Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses
2015
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
2017 StandoutNobel
New adjuvants for human vaccines
2010
Population-based screening for cancer: hope and hype
2016
The known unknowns of HPV natural history
2011
Designing deep learning studies in cancer diagnostics
2021
Pathogenic Escherichia coli
2004 Standout
Human papillomavirus and cervical cancer
2007 Standout
Deep learning in histopathology: the path to the clinic
2021 Standout
Midwifery and quality care: findings from a new evidence-informed framework for maternal and newborn care
2014 Standout
HPV-FASTER: broadening the scope for prevention of HPV-related cancer
2015
Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses
2016
Pyroptosis: A new frontier in cancer
2019 Standout
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
2017 Standout
Prevalence of Oral HPV Infection in the United States, 2009-2010
2012 Standout
The molecular landscape of head and neck cancer
2018 Standout
Overall survival after pelvic exenteration for gynecologic malignancy
2014
Global cancer patterns: causes and prevention
2013
Female-to-Male Patients Have High Prevalence of Unsatisfactory Paps Compared to Non-Transgender Females: Implications for Cervical Cancer Screening
2014
Global burden of cancers attributable to infections in 2012: a synthetic analysis
2016
Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions
2014
Surgical results of pelvic exenteration in the treatment of gynecologic cancer
2014
Cervical cancer
2019 Standout
Effect of HIV Infection on Human Papillomavirus Types Causing Invasive Cervical Cancer in Africa
2016
Cervical cancer is addicted to SIRT1 disarming the AIM2 antiviral defense
2018
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever
2010
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
2018 Standout
Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening
2019
HPV Vaccination and the Risk of Invasive Cervical Cancer
2020
CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection
2004 StandoutNobel
Primary Care Guidelines for the Management of Persons Infected With HIV: 2013 Update by the HIV Medicine Association of the Infectious Diseases Society of America
2013
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients
1996 StandoutNobel
Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner
2004 StandoutNobel
Worldwide burden of cancer attributable to HPV by site, country and HPV type
2017 Standout
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors
2018
Human Papillomavirus and Cervical Cancer
2003 Standout
Systematic Review of Genomic Integration Sites of Human Papillomavirus Genomes in Epithelial Dysplasia and Invasive Cancer of the Female Lower Genital Tract
2004
Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society
2020
Synergistically enhanced colorimetric molecular detection using smart cup: a case for instrument-free HPV-associated cancer screening
2019
Active versus expectant management for women in the third stage of labour
2015
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Growth of Pseudotypes of Vesicular Stomatitis Virus with N-Tropic Murine Leukemia Virus Coats in Cells Resistant to N-Tropic Viruses
1973 StandoutNobel
Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma
2015 Standout
Ribonucleic Acud Polymerase in Virions of Newcastle Disease Virus: Comparison with the Vesicular Stomatitis Virus Polymerase
1971 StandoutNobel
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
2014 Standout
Assessing Impact of HPV Vaccination on Cervical Cancer Incidence among Women Aged 15–29 Years in the United States, 1999–2017: An Ecologic Study
2020
Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
2003 StandoutNobel
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Imiquimod 3.75% Cream Applied Daily to Treat Anogenital Warts: Combined Results from Women in Two Randomized, Placebo-Controlled Studies
2011
Alanine Scanning of the Hepatitis C Virus Core Protein Reveals Numerous Residues Essential for Production of Infectious Virus
2007 StandoutNobel
Cervical-Cancer Screening with Human Papillomavirus and Cytologic Cotesting
2013
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
2006 StandoutNobel
Oncolytic Viruses in Cancer Treatment
2016
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV‐positive cancer cells
2013
E3 ubiquitin ligase Mindbomb 1 facilitates nuclear delivery of adenovirus genomes
2020 StandoutNobel
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.
1992 Standout
Works of Mark H. Einstein being referenced
Neonatal sepsis and death caused by resistant Escherichia coli: Possible consequences of extended maternal ampicillin administration
1999
Clinical validation of the Cervista® HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology
2010
2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors
2013
Human papillomavirus and cervical cancer
2013
Therapy of Human Papillomavirus-Related Disease
2012
2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors
2013
Human Papillomavirus and Cervical Neoplasia
2002
Association of bactericidal activity of genital tract secretions with Escherichia coli colonization in pregnancy
2012
Correlation between levels of human papillomavirus (HPV)-16 and 18 antibodies in serum and cervicovaginal secretions in girls and women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine
2010
Total pelvic exenteration: The Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003)
2006
How does public policy impact cervical screening and vaccination strategies?
2010
Cervical Intraepithelial Neoplasia Is Associated With Genital Tract Mucosal Inflammation
2012
Combined human papillomavirus DNA and human papillomavirus‐like particle serologic assay to identify women at risk for high‐grade cervical intraepithelial neoplasia
2006
Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18–45 years
2011
Intravenous administration of Reolysin®, a live replication competent RNA virus is safe in patients with advanced solid tumors
2009
Safety and Immunogenicity of the Quadrivalent Human Papillomavirus Vaccine in HIV‐1–Infected Men
2010
Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III
2007
Use of Primary High-Risk Human Papillomavirus Testing for Cervical Cancer Screening
2015
Clinician's guide to human papillomavirus immunology: knowns and unknowns
2009
Vaccine strategies for human papillomavirus-associated cancers
2005
Comparison of the immunogenicity and safety ofCervarix™ andGardasil®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years
2009
Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine
2011
Utilization of the human genome sequence localizes human papillomavirus type 16 DNA integrated into the TNFAIP2 gene in a fatal cervical cancer from a 39-year-old woman.
2002
Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: End-of-study analysis of a Phase III randomized trial
2014
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors
2020
Reliability of the Xpert HPV Assay to Detect High-Risk Human Papillomavirus DNA in a Colposcopy Referral Population
2014
An Observational Study of Deep Learning and Automated Evaluation of Cervical Images for Cancer Screening
2018
Clinical Evaluation of the Cartridge-Based GeneXpert Human Papillomavirus Assay in Women Referred for Colposcopy
2014
Genetic Variants in TAP Are Associated with High-Grade Cervical Neoplasia
2009